CATHEDRAL AESTHETICS LIMITED

Executive Summary

Cathedral Aesthetics Limited, a micro-entity specialist medical practice incorporated in 2023, exhibits significant solvency and liquidity concerns with negative net assets and a deficit in current assets. While regulatory compliance is up to date and ownership structure is clear, limited financial transparency and a short operating history increase risk. Further due diligence on liabilities, cash flow, and parent company support is advisable before investment consideration.

CATHEDRAL AESTHETICS LIMITED - Analysis Report

Company Number: NI695289

Analysis Date: 2025-07-29 18:18 UTC

1. Risk Rating: HIGH
   The company shows persistent negative net assets and current liabilities exceeding current assets, indicating solvency and liquidity risks. Its micro-entity status and lack of audit reduce financial transparency. The business is very new (incorporated 2023), with limited operational history, increasing uncertainty.

2. Key Concerns:

• Negative net assets worsening from -£4,227 in 2023 to -£6,869 in 2024, reflecting accumulated losses and undercapitalization.
• Negative current assets (-£17,435) suggest liabilities exceed short-term assets, raising liquidity and cash flow concerns.
• Lack of audit and minimal disclosures typical of micro-entity filings limit insight into financial and operational stability.

3. Positive Indicators:

• No overdue filings for accounts or confirmation statements, indicating compliance with regulatory deadlines.
• Clear ownership and control structure with identifiable parent company (Cathedral Eye Holdings Ltd) and significant shareholders, which may provide support.
• Single director actively involved, potentially allowing agile decision-making.

4. Due Diligence Notes:

• Verify nature and timing of current liabilities causing negative current assets; assess payment obligations and creditor terms.
• Review cash flow forecasts and funding plans to understand how the company intends to address negative working capital.
• Investigate relationship with parent company and any financial support or guarantees provided.
• Evaluate business model viability and client base given limited operational history and the specialist medical practice sector.
• Confirm no historical or ongoing director conduct issues given sole director status.
• Consider requesting management accounts and forecasts for deeper operational insight.